SkinHealth Systems Inc. (SKIN) Soars 9.0%: Is Further Upside Left in the Stock?

SkinHealth Systems (SKIN) jumped 9% after completing a 1-for-20 reverse stock split on October 14, 2026, a move that restored the company's compliance with Nasdaq's minimum bid price requirement.

The listing fix removes a delisting overhang, but the fundamentals tell a harder story. The company is expected to post a quarterly loss of $1.35 per share, a 1400% year-over-year deterioration. Revenue is projected to fall 5% to $67.18 million.

Analysts have not moved. Earnings estimate revisions are unchanged, and Zacks Rank sits at #3 (Hold). That points to a rally driven by the reverse split itself rather than by any improvement in the earnings outlook. Interpretation: a 1-for-20 split changes the per-share price, not the underlying business, so the 9% pop looks more like relief over the listing status than a re-rating of operations.

Note that the loss-per-share figure and the year-over-year comparison reflect the company's current share structure, and the shrinking top line leaves little to support a sustained move on its own.